SCHEMBL2301374

SCHEMBL2301374

Clc1cc(Cl)cc(OC2C[N]C2)c1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.37
SLC6A2 P23975 4/20 0.37
SLC6A3 Q01959 4/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
TSHR P16473 2/20 0.35
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
LMNA P02545 1/20 0.31
CYP2C9 P11712 1/20 0.31
APEX1 P27695 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAPT P10636 1/20 0.31
ACLY P53396 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2298742 0.80 SLC6A4 (0.57) SLC6A4SLC6A2SLC6A3LMNASMN1; SMN2
SCHEMBL2302743 0.78 SLC6A4 (0.52) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL14312031 0.74 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3CHRNB2CHRNA4
SCHEMBL2300977 0.74 SLC6A4 (0.62) SLC6A4SLC6A2SLC6A3TSHRTP53
SCHEMBL7726520 0.71 HRH1 (0.55) SLC6A4SLC6A2SLC6A3CHRNB2CHRNA4
SCHEMBL19083886 0.71 SLC6A4 (0.41) SLC6A4SLC6A2SLC6A3
SCHEMBL2300752 0.70 SLC6A4 (0.45) SLC6A4SLC6A2SLC6A3CYP3A4CYP2C9
SCHEMBL2297174 0.69 FPR2 (0.44) SLC6A4SLC6A2SLC6A3LMNAMAPT
SCHEMBL2296925 0.69 GRIN1 (0.39) SLC6A4SLC6A2SLC6A3
SCHEMBL2301256 0.68 HRH1 (0.52) SLC6A4SLC6A2SLC6A3CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536689-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN Amgen Inc. (US) 2012-12-26 EP disclosed
WO-2011103196-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN AMGEN INC. (US) 2011-08-25 WO disclosed